PMID- 17697600 OWN - NLM STAT- MEDLINE DCOM- 20081010 LR - 20070816 IS - 0529-567X (Print) IS - 0529-567X (Linking) VI - 42 IP - 6 DP - 2007 Jun TI - [Study of the mechanism of mast cell increase in cellular leiomyoma of uterus]. PG - 390-3 AB - OBJECTIVE: To study the mechanism of mast cell increase in cellular leiomyoma of uterus. METHODS: Tissue sections from 30 cases of cellular leiomyoma of uterus, 15 cases of leiomyosarcoma and 30 cases of ordinary leiomyoma were studied using immunohistochemical double labeling techniques. The expression of mast cell tryptase and Ki-67 as well as mast cell tryptase and chemotactic factors RANTES, Eotaxin, monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-beta (TGF-beta) were double immunostained. RESULTS: Ki-67 in mast cells was rarely expressed in each group. Expressions of regulate upon activation normal T cell expressed and secreted (RANTES), Eotaxin and TGF -beta in cellular leiomyoma were 78%, 89%, 91%, respectively. They were all higher than those in ordinary leiomyoma and leiomyosarcoma (P < 0.01), which were 60%, 81%, 86% and 39%, 44%, 59%, respectively. There were positive correlations between RANTES and the number of mast cells (r = 0.655, P < 0.01) as well as between Eotaxin and the number of mast cells (r = 0.543, P < 0.01). However, expression of MCP-1 was not observed in tumor cells in any group. CONCLUSIONS: Mast cell increase in cellular leiomyoma of the uterus is due to local recruitment of mast cells. RANTES and Eotaxin secreted by smooth muscle tumor cells correlates with the recruitment of mast cells, but MCP-1 and TGF-beta do not. FAU - Lu, Jie-Qiang AU - Lu JQ AD - Department of Obstetrics and Gynecology, Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China. FAU - Zhu, Xue-Qiong AU - Zhu XQ FAU - Dong, Ke AU - Dong K FAU - Xiang, Mei AU - Xiang M FAU - Lin, Yi AU - Lin Y FAU - Hu, Yue AU - Hu Y LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Fu Chan Ke Za Zhi JT - Zhonghua fu chan ke za zhi JID - 16210370R RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Chemotactic Factors) RN - 0 (Ki-67 Antigen) SB - IM MH - Adult MH - Cell Count MH - Chemokine CCL2/biosynthesis MH - Chemokine CCL5/biosynthesis MH - Chemotactic Factors/*biosynthesis MH - Female MH - Humans MH - Immunohistochemistry MH - Ki-67 Antigen/biosynthesis MH - Leiomyoma/*metabolism/pathology MH - Leiomyosarcoma/metabolism/pathology MH - Mast Cells/*metabolism/pathology MH - Middle Aged MH - Uterine Neoplasms/*metabolism/pathology EDAT- 2007/08/19 09:00 MHDA- 2008/10/11 09:00 CRDT- 2007/08/19 09:00 PHST- 2007/08/19 09:00 [pubmed] PHST- 2008/10/11 09:00 [medline] PHST- 2007/08/19 09:00 [entrez] PST - ppublish SO - Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):390-3.